Advances in Skin & Wound Care

Secondary Logo

Journal Logo

Words on Wounds

A forum to discuss the latest news and ideas in skin and wound care.

Tuesday, February 11, 2020

Wound Care Advocacy in Action: The Wound Care Evidence Summit and Other Updates from the Alliance of Wound Care Stakeholders
The Alliance of Wound Care Stakeholders is convening an inaugural “Wound Care Evidence Summit” April 1 and 2, 2020 in Washington, DC to tackle challenges in wound care evidence that impact Medicare and commercial payer coverage and that play a role in increasingly restrictive coverage policy trends. The Summit will convene commercial and government payer medical directors, FDA, AHRQ, and NIH senior staff, wound care researchers, physician specialty societies, clinical associations, wound care providers, researchers, manufacturers, and policymakers to tackle issues including:
  • How can we improve the effectiveness of chronic wound care clinical management?
  • What outcomes are most important to patients, as well as to regulatory, payer and other stakeholders?
  • How can we reduce unnecessary costs and improve the cost-effectiveness of care?
  • What type and quantity of research do payers require to cover wound care products and procedures?
  • What role should real-world data play in research, and what real-world evidence will be acceptable to regulators, clinicians and payers?
For more information and a full agenda of the summit, visit

Further, the Alliance has achieved several recent advocacy successes, including: 
  • Based on Alliance advocacy and an LCD Reconsideration Request led by the American Podiatric Medical Association (an Alliance member), Medicare Administrative Contractor WPS rewrote/revised its highly problematic wound care local coverage determination that had significant restrictions on debridement and dNPWT conflicting current standards of care. The re-issuance of the LCD follows three years of advocacy/comments/testimonies by the Alliance on this issue, and they are pleased to see the success of the wound care community coming together to make sure that providers are not egregiously restricted on providing standard of care treatment to patients. 
  • HCPCS coding reforms that the Alliance has long advocated were put in place in 2020, which should speed the time in which new wound care products can come to market. This has a direct impact on the manufacturers who are developing products, but of course also impacts providers and patients in that new treatment options can reach the market quicker. 
For the full Advocacy Update from the Alliance, visit, or go to their website,, for all the latest information on these and other initiatives.